Wu Peihong, graduated from the Department of Medicine, Zhongshan Medical University in 1982. He is currently the director of the Imaging and Minimally Invasive Intervention Center of Sun Yat-sen University Affiliated Tumor Hospital, second-level professor, first-level chief physician, doctoral supervisor and postdoctoral supervisor. Rochester University (Rochester) School of Medicine, Canada University of Toronto School of Medicine Clinical Visiting Professor, Sun Yat-sen University Famous Doctor, Top 10 Minimally Invasive Intervention Therapy in China's Top 100 Famous Doctors.



Part-time professional society:

Executive Director of China Anti-Cancer Association (2007-present)

Executive Director of the Asian Society of Ablation (2014-present)

Chairman of the Society of Minimally Invasive Tumor Therapy under the guidance of Asia Pacific Imaging (2014-present)

Honorary Chairman of the Professional Committee of Minimally Invasive Tumor Therapy of China Anti-Cancer Association (2006-present)

Group Leader of Tumor Ablation Therapy Group under the Image-guided Tumor Minimally Invasive Therapy Committee of China Anti-Cancer Association (2008-present)

Chairman of the Committee of Expert Committee on Minimally Invasive Tumor Therapy under the guidance of imaging guidance of the Chinese Anti-Cancer Association Minimally Invasive Tumor Therapy Committee (2013-present)

Chairman of the Committee of Expert Committee on Minimally Invasive and Comprehensive Treatment of Liver Cancer under the Image-guided Committee of the Chinese Anti-Cancer Association

Honorary Chairman of Particle Therapy Group of China Anti-Cancer Association Minimally Invasive Tumor Therapy Professional Committee (2007-present)

Deputy Chairman of the Interventional Physician Branch of Guangdong Medical Association (2011-present)

Deputy Chairman of Guangdong Medical Association Biological Cell Therapy Association (2012-present)

Vice Chairman of Guangdong Cell Therapy Association (2009-present)

Honorary Chairman of the Professional Committee of Tumor Imaging and Interventional Diagnosis and Treatment of Guangdong Anti-Cancer Association (2011-present)

Chairman of the Professional Committee of Minimally Invasive Tumor Therapy of Guangzhou Anti-Cancer Association (2002-present)

Member of the Standing Committee of the Interventional Oncology Committee of the Chinese Anti-Cancer Association (2001-present)

Member of the Standing Committee of the Guangdong Society of Radiology (1994-present)

Professional magazine editor (reviewer):

Editorial Board Member of "Chinese Medical Journal" (2009-present)

Editorial Board Member of "Chinese Journal of Oncology" (2009-present)

Standing Editor of "Journal of Interventional Radiology" (2003-present)

Standing editorial board member of "Cancer" magazine. (2003-present)

Part-time job at Sun Yat-sen University and Cancer Hospital:

Member of "Academic Committee" (2010-present)

Director of "Image and Diagnostic System Academic Committee" (2010-present)

Member of "Medical Quality Management Committee" (2010-present)

Deputy Director of the Radiological Protection Committee (2010-present)

Member of Guangdong Province and Guangzhou Municipal Health Committee

Member of "Medical Consumables Management Committee" (2010-present)



Overseas study experience:

From 1999 to 2000, he was a visiting scholar at MD.Anderson Cancer Center and Iowa University in the United States to study and exchange tumor imaging diagnosis and minimally invasive interventional therapy.



Clinical medical experience:

It has a solid foundation in medical clinical oncology and imaging, minimally invasive interventional diagnosis and treatment of tumors. Proficiency in the comprehensive application of multiple minimally invasive interventional techniques for tumor treatment. He has more than 30 years of experience in tumor diagnosis and treatment, and various minimally invasive interventional procedures have reached more than 15,000 people. In particular, he has rich experience in liver cancer, lung cancer, breast cancer, cervical cancer, uterine fibroids, abdominal and pelvic tumor intervention, ablation treatment, and seed implantation. Established the concept of radical minimally invasive interventional tumor treatment and minimally invasive interventional tumor lymph node dissection, and applied it to the field of comprehensive tumor treatment; extended the concept of radical tumor treatment to the local inactivation of the tumor, the level and area of the organ where the tumor is located The inactivation of cancer cells at the systemic level. Create and promote a new model of tumor treatment, namely, image-guided minimally invasive or non-invasive treatment combined with biological, molecular targeted therapy, and Chinese medicine treatment of individualized, humanized, rational, and constructive tumor treatment models, which are effective in treating Under the premise of tumor, the physiological function and immune function of the human body are protected to the greatest extent. Established and promoted the transformation of the basic model of interventional therapy for liver cancer, namely TACE sequential combined ablation therapy and biological therapy, which significantly improved the curative effect of liver cancer, reached the world's leading level, reduced liver damage, and improved the quality of life of patients. He is one of the initiators of non-invasive, minimally invasive and comprehensive treatment of breast cancer, and actively promotes the individualized, humanized, and rational constructive treatment of breast cancer. Carry out minimally invasive interventional treatment of a variety of tumors, such as tumor embolization chemotherapy, hemangioma embolization; arterial catheter kit system placement to treat head and neck, chest and abdomen, pelvic cavity, limb tumors; minimally invasive interventional treatment of uterine fibroids; stents Installation treatment of intravenous, arterial and luminal obstruction and stenosis; bone cement vertebroplasty to treat bone metastases; guided biopsy, etc. It is the first in China to carry out intervention-oriented biological gene therapy, arterial chronotherapy, and the combination of tumor anti-vascular therapy (embolization chemotherapy) and anti-neovascular therapy to further improve the efficacy. He has been invited to give lectures at important academic conferences at home and abroad. Co-chairman of WCIO (World Conference on Interventional Oncology); chaired the conference to hold ten National Conferences on Minimally Invasive Tumor Therapy, six National Conferences on Tumor Ablation Therapy, and the first Asia-Pacific Conference on Minimally Invasive Tumor Therapy under imaging guidance



Scientific research experience:

Long-term development of basic and clinical research on minimally invasive interventional therapy for tumors, published more than 200 papers, including more than 40 SCI articles; responsible for the National Natural Science Foundation of China, the National 863 project (the second host and sub-head of the project), There are more than 10 projects in the Ninth Five-Year Plan, the Ministry of Health, the Provincial Natural Science Foundation, the Provincial Science and Technology Commission, the Provincial Health Department, and the 211 Project. Editor-in-chief of 7 monographs, ① "Minimally Invasive Treatment of Liver Cancer and Multidisciplinary Comprehensive Therapy", ② "Tumor Interventional Diagnosis and Treatment", ③ "Tumor Ablation Therapy", ④ "Spiral CT Diagnosis", ⑤ "MRI. Must Read for Clinicians ", ⑥ Ministry of Health medical audio-visual textbook "Nasopharyngeal Carcinoma Imaging Diagnosis"; ⑦ Irreversible electroporation ablation technology application principle and practice. The chief reviewer of the monograph "CT Interventional Therapy"; the deputy editor-in-chief of "Basic and Clinical Application of Tumor Biotherapy"; the editorial board of more than 10 monographs including "Clinical Oncology" and "Oncology". Among them, "Tumor Interventional Diagnosis and Treatment" published by Science Press won the National Science and Technology Academic Publication Fund.



Teaching experience:

Served as the director of the medical imaging teaching and research section of Sun Yat-sen University Cancer Hospital, presided over the training and teaching tasks of undergraduates, postgraduates, imaging professional classes, and advanced students in and outside the province. In 1995 and 2003, he was hired as a postgraduate of imaging medicine and oncology in the Affiliated Tumor Hospital of Sun Yat-sen University. Supervisor, doctoral tutor, post-doctoral tutor; hosting the national continuing medical education class "Minimally Invasive Tumor Treatment and Tumor Imaging" for ten consecutive years.